PUBLISHED: 2014
CATEGORY: Health care providers
TYPE: External Link Advice for the Use of the Multicomponent Meningococcal Serogroup B (4CMenB) Vaccine
Advice for the Use of the Multicomponent Meningococcal Serogroup B (4CMenB) Vaccine Advice for the Use of the Multicomponent Meningococcal Serogroup B (4CMenB) Vaccine
This statement updates the epidemiology of IMD in Canada; provides available vaccine efficacy, effectiveness, immunogenicity and safety information on 4CMenB vaccine; identifies evidence gaps and ongoing research, evaluation and surveillance needs; and provides recommendations for use of the 4CMenB vaccine in Canada.
Authors: National Advisory Committee on Immunization
Corporate Authors: National Advisory Committee on Immunization
Publisher: Publisher
Public Health Agency of Canada
